Literature DB >> 28657968

Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis.

Richard E Haaland1, Amy Martin, Angela Holder, Jeffrey J Fountain, LaShonda Hall, Nicole A Pescatore, Sheila Heeke, Colleen F Kelley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28657968      PMCID： PMC5541255          DOI： 10.1097/QAD.0000000000001551

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  16 in total

1.  A case study of chewed Truvada® for PrEP maintaining protective drug levels as measured by a novel urine tenofovir assay.

Authors:  Linden Lalley-Chareczko; Devon Clark; Athena F Zuppa; Ganesh Moorthy; Caitlin Conyngham; Karam Mounzer; Helen Koenig
Journal:  Antivir Ther       Date:  2017-03-06

2.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

3.  Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).

Authors:  Laxmaiah Manchikanti; Yogesh Malla; Bradley W Wargo; Kimberly A Cash; Vidyasagar Pampati; Kim S Damron; Carla D McManus; Doris E Brandon
Journal:  Pain Physician       Date:  2010 Jan-Feb       Impact factor: 4.965

4.  Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.

Authors:  Jose R Castillo-Mancilla; Jia-Hua Zheng; Joseph E Rower; Amie Meditz; Edward M Gardner; Julie Predhomme; Caitlin Fernandez; Jacob Langness; Jennifer J Kiser; Lane R Bushman; Peter L Anderson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-10       Impact factor: 2.205

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.

Authors:  Victoire de Lastours; Julien Fonsart; Ruxandra Burlacu; Bernard Gourmel; Jean-Michel Molina
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 8.  Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.

Authors:  Jessica E Haberer
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

9.  Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures.

Authors:  Sanjiv M Baxi; Albert Liu; Peter Bacchetti; Gaudensia Mutua; Eduard J Sanders; Freddie M Kibengo; Jessica E Haberer; James Rooney; Craig W Hendrix; Peter L Anderson; Yong Huang; Frances Priddy; Monica Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

10.  HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Authors:  Deborah Donnell; Jared M Baeten; Namandjé N Bumpus; Justin Brantley; David R Bangsberg; Jessica E Haberer; Andrew Mujugira; Nelly Mugo; Patrick Ndase; Craig Hendrix; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731
View more
  4 in total

1.  A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women.

Authors:  Tamsin K Phillips; Phumla Sinxadi; Elaine J Abrams; Allison Zerbe; Catherine Orrell; Nai-Chung Hu; Kirsty Brittain; Yolanda Gomba; Jennifer Norman; Lubbe Wiesner; Landon Myer; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

2.  Antiretroviral Concentration in Hair as a Measure for Antiretroviral Medication Adherence: A Systematic Review of Global Literature.

Authors:  Quan Zhang; Shan Qiao; Xueying Yang; Xiaoming Li
Journal:  AIDS Behav       Date:  2020-01

3.  Brief Report: Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men.

Authors:  Richard E Haaland; Amy Martin; Tamee Livermont; Jeffrey Fountain; Chuong Dinh; Angela Holder; Lindsey D Lupo; LaShonda Hall; Christopher Conway-Washington; Colleen F Kelley
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

4.  Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART.

Authors:  Hideaki Okochi; Alexander Louie; Nhi Phung; Kevin Zhang; Regina M Tallerico; Karen Kuncze; Matthew A Spinelli; Catherine A Koss; Leslie Z Benet; Monica Gandhi
Journal:  Drug Test Anal       Date:  2021-04-13       Impact factor: 3.234
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.